Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type

3 total trials

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

A research study looking at the effect of semaglutide on the immune system and other biological processes in people with Alzheimer's disease Ended

2023-506825-13-00 5 2023-07-25
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Ended

2023-506918-45-00 5 2021-05-17
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Ended

2023-506919-18-00 5 2021-05-17

Showing 1–3 of 3 trials